May 12, 2026 04:18PM
May 7, 2026 07:42AM
May 7, 2026 07:00AM
Apr 27, 2026 02:55PM
Apr 27, 2026 07:01AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator 
Apr 27, 2026 07:00AM
Apr 22, 2026 07:00AM
Feb 26, 2026 07:11AM
Feb 26, 2026 07:00AM
Feb 12, 2026 07:00AM
Dec 10, 2025 08:46AM
Dec 9, 2025 07:00AM Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Nov 10, 2025 04:10PM
Nov 6, 2025 07:21AM
Nov 6, 2025 07:00AM
Oct 23, 2025 07:00AM
Sep 2, 2025 07:37AM
Aug 7, 2025 07:12AM
Aug 7, 2025 07:00AM Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
Jul 24, 2025 07:00AM
Jul 2, 2025 07:01AM
Jul 2, 2025 07:00AM
Jul 2, 2025 07:00AM
May 8, 2025 07:14AM
May 8, 2025 07:00AM
Apr 24, 2025 07:00AM Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
Apr 17, 2025 06:00AM
Feb 27, 2025 07:12AM
Feb 27, 2025 07:00AM
Feb 13, 2025 07:00AM
Dec 23, 2024 10:18AM
Dec 10, 2024 09:15AM
Dec 10, 2024 09:00AM Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
Nov 7, 2024 07:17AM
Nov 7, 2024 07:00AM
Oct 23, 2024 04:01PM
Aug 6, 2024 04:01PM
Jul 23, 2024 04:01PM
Jul 9, 2024 08:50AM
Jul 8, 2024 07:03AM Ligand Pharma (LGND) to Buy Apeiron Biologics for $100M Cash
Jul 8, 2024 07:00AM
May 7, 2024 04:54PM
May 7, 2024 04:00PM
Apr 23, 2024 08:31AM
Feb 27, 2024 07:11AM
Feb 27, 2024 07:00AM
Feb 13, 2024 04:01PM Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
Dec 12, 2023 12:01PM

1,198,733 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All